Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Peripherally Inserted Central Catheters have been widely used for many years for the administration of chemotherapy to patients with cancer. However, its use entails significant infectious complications and high risks of death.The hypothesis is that increasing the rate of PICCline dressing changes will reduce the occurrence of catheter-related infections.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient with a diagnosis of acute myeloblastic leukemia.

• Patient going on intensive induction chemotherapy (causing a high risk situation of severe infection defined as profound neutropenia ( Polymorphonuclear neutrophil count \<500/mm3) and lasting (\>7 days).

• Patients who have had a PICCline placed within the last 24 hours or who require a PICCline placement as part of their hospitalization under optimal hygiene and asepsis conditions.

• Patient housed in a protected environment (flow chamber or Plasmair®).

• Patient who has given free and informed consent.

• Patient affiliated or beneficiary of a health insurance plan.

• Adult patient (≥18 years old).

Locations
Other Locations
France
CHU de Montpellier Hôpital St-Eloi
RECRUITING
Montpellier
Contact Information
Primary
Éric JOURDAN, Dr.
Eric.jourdan@chu-nimes.fr
+334.66.68.32.34
Backup
Anissa MEGZARI
drc@chu-nimes.fr
+33466684236
Time Frame
Start Date: 2023-06-06
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 60
Treatments
Active_comparator: Control group
Patients receiving normal management with dressings changed once a week according to the SF2H recommendations.
Experimental: Experimental group
Patients whose dressings are changed every other day.
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Nīmes
Collaborators: University Hospital, Montpellier

This content was sourced from clinicaltrials.gov